XCures Raises $46 Million Series B for AI Medical Records Platform
XCures closed a $46 million Series B led by Innovius Capital, doubling its valuation to $127 million post-money and bringing total funding to $76 million since 2018.
XCures closed a $46 million Series B financing led by Innovius Capital, with participation from iGrow, Spring Mountain Capital, and existing investors [1]. The round values the company at $127 million post-money, more than double the valuation of its $25 million Series A in December 2023, and brings total funding to $76 million since its 2018 inception as a spinout from Cancer Commons [1].
The company processes unstructured patient data from more than 550,000 healthcare locations nationwide, having ingested over 300 million medical records to date [1]. CEO Mika Newton said the platform turns "dirty data" — duplicative scans, narrative notes, and human-entry errors arriving via fax and interoperability networks — into "clinical intelligence" through a proprietary governance framework that orchestrates home-built machine learning models alongside commercial frontier models [1]. The Clinical Clarity Engine generates decision-ready checklists, automates patient histories for operating room scheduling, and supports prior authorizations for Medicare Advantage plans [1].
Continue reading
3 more paragraphs for subscribers.
Free readers get a daily preview and the weekly long-form. Premium unlocks every brief in full, AM & PM editions, alerts, and the archive.